Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
October 1994
in “Annals of Oncology”
TLDR Minoxidil not effective in preventing chemotherapy-induced hair loss.
The study evaluated the effectiveness of Minoxidil (Mx) 2% topical solution in preventing doxorubicin-induced alopecia in 48 female cancer patients. The patients were randomly assigned to receive either Mx or a placebo, and both groups showed severe alopecia with no significant difference between them. The study concluded that Mx 2% topical solution was non-toxic but not effective in preventing chemotherapy-induced alopecia. The study suggests that few trials have been conducted to prevent chemotherapy-induced alopecia, and Mx, which is used to induce hair growth in men with male-pattern baldness, was not effective in preventing doxorubicin-induced alopecia.
View this study on annalsofoncology.org →
Related
research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil
Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
research Role of low dose oral minoxidil in the treatment of hair loss: A review
research Minoxidil and its use in hair disorders: a review
Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.
research Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil
Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.
research Chemotherapy-induced hair loss.
research Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
Minoxidil not effective in preventing chemotherapy-induced hair loss.
research Androgenetic Alopecia in the Female
2% topical minoxidil effectively treats female hair loss with minimal side effects.
research USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN
Minoxidil helps hair growth and reduces shedding in women.